F
Fei Deng
Researcher at Chinese Academy of Sciences
Publications - 230
Citations - 23129
Fei Deng is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Virus & Medicine. The author has an hindex of 31, co-authored 197 publications receiving 16159 citations. Previous affiliations of Fei Deng include Nankai University.
Papers
More filters
Journal ArticleDOI
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Posted ContentDOI
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
TL;DR: The identification and characterization of a novel coronavirus (nCoV-2019) which caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China, and it is confirmed that this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.
Journal ArticleDOI
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Mei Qin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
Journal ArticleDOI
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
Xi Wang,Ruiyuan Cao,Huanyu Zhang,J.D. Liu,Mingyue Xu,Hengrui Hu,Yufeng Li,Lei Zhao,Wei Li,Xiulian Sun,Xing-Lou Yang,Zhengli Shi,Fei Deng,Zhihong Hu,Wu Zhong,Manli Wang +15 more
TL;DR: Six currently available and licensed anti-influenza drugs against SARS-CoV-2 are evaluated and it is suggested that arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate of COVID-19 patients.
Journal ArticleDOI
Proteomics of the Autographa californica Nucleopolyhedrovirus Budded Virions
TL;DR: The protein composition of the BV of Autographa californica nucleopolyhedrovirus (AcMNPV), the type species of baculoviruses, was analyzed by various mass spectrometry techniques, suggesting that many enveloped viruses may commonly utilize certain conserved cellular pathways.